page contents

sites

Friday, 11 January 2013

Treatment For Breast Cancer

Source(google.com.pk)
Treatment For Breast Cancer Biography
Biological therapy uses the body's own immune system (its antibodies) to fight breast cancer cells, while leaving healthy cells unaffected.

One such antibody is Herceptin, a monoclonal (meaning single) antibody. An antibody is a protein made by the body's own immune system. But Herceptin can work only if the woman carries the HER2 gene in those tumor cells. About 25% of breast cancer patients carry this gene and are considered HER2 positive.

Herceptin is the first-line treatment of HER2-positive metastatic breast cancer in combination with chemotherapy drugs. Herceptin may also be used alone, indefinitely for HER2- positive metastatic breast cancer.

Perjeta (pertuzumab) is another monoclonal antibody approved for treatment of HER2-positive metastatic breast cancer. It is approved for use in combination with Herceptin and the chemotherapy Taxotere.

Another drug of this type is Tykerb. It works in HER2-positive patients when Herceptin is no longer effective. It is used in combination with Xeloda, Femara, or Herceptin.

Other types of antibodies are being researched to fight cancer and include:

Angiogenesis Inhibitors.
 These antibodies prevent the growth of new blood vessels, cutting off the supply of oxygen and nutrients to cancer cells. However, the only such drug used for breast cancer, bevacizumab, lost its FDA approval for breast cancer because the drug's risks outweighed its benefits and it didn't improve the overall survival of breast cancer patients.

Signal Transduction Inhibitors.
These antibodies block signals inside the cancer cell that helps the cells divide, stopping the cancer from growing. They are currently being studied to see if they're effective.
Before treatment begins, print out these Questions to Ask to help you better understand your care.

Also see, Follow-Up Care After Your Treatment.

Side Effects of Biological Therapy for Breast Cancer
When biological therapy is used to treat breast cancer, side effects can include:

Allergic reactions
Difficulty breathing
Swelling
Nausea
Fever and chills
Dizziness or weakness
Talk to your doctor about the possible side effects to watch for and what you should do if they occur. The FDA has warned that the treatment with Perjeta may be harmful or fatal to a fetus. Women who are pregnant should not take Perjeta.

Recognizing a Breast Cancer Emergency
If you develop fever and chills, notify your doctor immediately or go to the emergency room. Other symptoms to tell your health care provider about include:

New mouth sores, patches, swollen tongue, or bleeding gums.
Dry, burning, scratchy, or "swollen" throat.
Cough that is new or persistent and produces mucus.
Changes in bladder function, including increased frequency or urgency to go; burning during urination; or blood in your urine.
Changes in gastrointestinal function, including heartburn; nausea, vomiting, constipation, or diarrhea that lasts longer than two or three days; or blood in stools.

Biological therapy for breast cancer takes advantage of the body's own immune or hormonal system to act on cancer cells - while leaving healthy cells relatively intact. This approach is designed to minimize the side effects associated with traditional treatments like chemotherapy.

One strategy is to use antibodies to attack cancer cells or block their activities. An antibody is a protein that can attach to specific proteins in the body, called antigens. Antibodies can be natural, made by one's own immune system, or made artificially. One example of a manufactured antibody is Herceptin.

Herceptin is believed to act in three ways to stop cancer cells from growing quickly and out of control:

It sticks to special receptors on the cancer cells, stopping them from growing.
It signals the body's own natural killer cells to attack the cancer cells.
It can work with chemotherapy medications, stopping cancer cells damaged by chemo from repairing themselves.
But Herceptin can work only if the woman carries the HER-2 gene in those tumor cells. About 25% of breast cancer patients carry this gene. (They are considered HER-2 positive). It currently is the first-line treatment of HER-2-positive metastatic breast cancer used in combination with one of the drugs known as taxanes (Taxotere, Taxol, and Abraxane).

Another form of biological therapy is the use of drugs composed of small molecules that interrupt the hormonal or chemical pathways that cancer cells need to grow. Tykerb is an example of a small molecule that is used in combination with chemotherapy to treat some advanced cases of breast cancer.

One disadvantage of antibody treatment is that it is generally only available by injection. Small molecule treatment can be taken in pill form.

A third drug, Perjeta, has recently been approved by the FDA to treat HER-2-positive metastatic breast cancer used in combination with Herceptin and Taxotere.

Other types of antibodies and small molecules that are being researched to fight breast cancer include:

Angiogenesis inhibitors. These antibodies prevent the growth of new blood vessels, cutting off the supply of oxygen and nutrients to cancer cells. Avastin, which had been used to treat breast cancer, is no longer approved by the FDA because the risks outweigh the benefits.
Signal transduction inhibitors. These antibodies block signals inside the cancer cell that helps the cells divide, stopping the cancer from growing.

Side Effects of Biological Therapy
Side effects of biological therapy can include allergic reactions, difficulty breathing, swelling, nausea, fever or chills, and dizziness or weakness. Talk to your doctor about the possible side effects to watch for.

Recognizing a Cancer Emergency
Call your nurse or doctor about your cancer if you have:

A temperature greater than 100.4 degrees Fahrenheit. If you experience any fever and chills, notify your doctor immediately. If you are unable to contact your doctor, go to the emergency room.
New mouth sores or patches, a swollen tongue, or bleeding gums
A dry, burning, scratchy, or "swollen" throat
A cough that is new or persistent and produces mucus
Changes in bladder function, including increased frequency or urgency to go, burning during urination, or blood in your urine
Changes in gastrointestinal function, including heartburn, nausea, vomiting, constipation, or diarrhea that lasts longer than two or three days
 Blood in stools
Treatment For Breast Cancer
Treatment For Breast Cancer
Treatment For Breast Cancer
Treatment For Breast Cancer
Treatment For Breast Cancer
Treatment For Breast Cancer
Treatment For Breast Cancer
Treatment For Breast Cancer

Treatment For Breast Cancer
Treatment For Breast Cancer

Thursday, 10 January 2013

What Are Symptoms Of Oral Cancer

Source(google.com.pk)
What Are Symptoms Of Oral Cancer Biography
Mouth cancer, also known as oral cancer, is a type of cancer in which malignant cells start developing inside the tissues lining the mouth. This type of cancer can be cured if it is diagnosed and treated on time. The risk factors and causes of oral cancer are-

Smoking and drinking alcohol- Smoking any form of tobacco – cigarettes, pipes or cigars – and excessive alcohol consumption are the major risk factors for mouth cancer. Smokers are at a higher than average risk of getting oral cancer, Mouth cancer also occurs in people who have never drunk or smoked, but this is uncommon.

Diet- An improper diet may increase the risk of mouth cancer due to a lack of zinc or other vitamins and minerals. A diet high in fresh fruit and vegetables seems to reduce the risk of developing cancer of the mouth. A diet rich in fresh fruits and vegetables is known to decrease the risk of getting mouth cancer.

Low immunity- People who are having a reduced immunity due to HIV or AIDS are at a greater risk of developing mouth cancer. Taking medicines for suppressing immunity after organ transplantations also increases the risk of mouth cancer.

Previous history of cancer- People who have suffered from mouth cancer earlier have an increased risk of getting it for the second time. Women have a higher risk of getting mouth cancer for the second time. People who have had some other types of cancer also have an increased risk of oral cancer.

The common symptoms of mouth cancer are:-

Ongoing pain or discomfort inside the mouth- This is one of the commonest symptoms of mouth cancer.

Mouth ulcers- Mouth ulcers which are not healing easily are also a common symptom of mouth cancer. 80% people with mouth cancer have this symptom (80%) have a mouth ulcer that does not heal.

Difficulty in swallowing- Pain or a burning sensation while chewing and swallowing food is a symptom of mouth cancer. The patient may even feel that the food is sticking in his throat after swallowing.

Speech problems- Mouth cancer can affect the voice. The voice may become quieter or husky.

A lump in the neck- This may be caused by an enlarged lymph node because of the cancer.

Weight loss- It is a common symptom of many cancers. Extreme weight loss may be a sign of advanced cancer.
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer
What Are Symptoms Of Oral Cancer

Oral Mouth Cancer

Source(google.com.pk)
Oral Mouth Cancer Biography
Abstract—One of the major problems related to cancer treatment is its recurrence. Without knowing in advance how likely
the cancer will relapse, clinical practice usually recommends
adjuvant treatments that have strong side-effects. A way to
optimize treatments is to predict the recurrence probability by
analysing a set of bio-markers. The NeoMark European project
has identified a set of preliminary bio-markers for the case of
oral cancer by collecting a large series of data from genomic,
imaging and clinical evidences. This heterogeneous set of data
needs a proper representation in order to be stored, computed
and communicated efficiently. Ontologies are often considered the
proper mean to integrate biomedical data, for their high level of
formality and for the need of interoperable, universally accepted,
models. This paper presents the NeoMark system and how an
ontology has been designed to integrate all its heterogeneous data.
The system has been validated in a pilot which data will populate
the ontology and will be made public for further research.
Index Terms—Cancer, Genetic expression, Computer aided
diagnosis, Biomedical image processing
I. INTRODUCTION
Cancer is the second cause of death in western countries.
Although current treatments can be effective, the main problem of cancer is its recurrence either locally or by distant
metastases, which are difficult to predict and prevent. The Oral
Squamous Cell Carcinoma (OSCC), focus of this research,
accounts for the 5% of all cancers, and has a rate of 25
to 50% of recurrence in 5 years, 90% of which within two
years from surgery [1]. In order to avoid relapses, adjuvant
chemo or radio-therapy treatments are usually administered
to all patients during follow-up, even in absence of disease
signs. These treatments are heavy and have strong side-effects
that may harm also patients who are in fact already completely
recovered. Knowing in advance which patients have the higher
risk of disease recurrence, would help to initiate adjuvant treatments only in a limited, high-risk subgroup. In addition, the
early identification of a neoplastic recurrence during follow-up
would allow starting an appropriate treatment in time.
D.Salvi, M.T. Arredondo and M.F. Cabrera are with Life Supporting Technologies, Universidad Politecnica
The most classical method to predict OSCC recurrence is
the TNM staging, which is based mainly on the dimensional
characteristics of the tumour and on the presence, number and
site of neck nodes metastasis. Unfortunately, its inadequacy
is today recognised because of the uncertain behaviour of
squamous cancer, which can be sometimes very aggressive
and others can metastasize slowly after surgery [2]. This
uncertainty in progression has led researchers to seek a
larger number of markers. Many clinical, histopathological,
radiological and genetic factors were studied, but none of the
different groups taken, distinctly provides clinically applicable
markers of tumour aggressiveness [3]. Given the multi-level
nature of cancer (genes, cells, tissues, organs) integration of
the different groups of data is required. Whereas different
reports are present in literature on data integration and creation
of standardized prognostic algorithms for bladder and breast
cancer, nothing is available for head and neck cancer. To cover
this lack, the NeoMark project was created.
NeoMark [4] is an European co-funded research project
which aimed at identifying the optimal set of patient-specific
and disease-specific bio-markers with a high predictive power
for the case of OSCC cancer.
The NeoMark strategy is designed to be integrated into
normal staging and follow-up protocols. Patients are assessed
before treatment and, at the time of remission, a wide range
of data is collected including clinical observations, radiologic
and genomic data. A set of relevant markers expressed only in
presence of the disease is then selected and relapse probability
is estimated. If the same set of bio-markers appears during
post-remission follow-up, it would show a high probability of
relapse, advising early intervention.
This strategy is supported by an Information and Communications Technology (ICT) based system which allows
physicians to:
administer patients
upload clinical data including histological information,
surgery evidence, and risk factors
analyse jointly multiple images from MR/CT scans
analyse gene expressions by means of micro-arrays and
a mobile PCR system
receive indicators of the probability of relapse for supporting the clinical decision during the follow-up
download anonymised data for further research and statistics
The following sections describe the details of the NeoMark
system, how an ontology for integrating all the data collected
in the system has been designed, some results of the pilot we

Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer
Oral Mouth Cancer

What Is Mouth Cancer

Source(google.com.pk)
What Is Mouth Cancer Biography
Often,l Researchers Discover Oral Cancer Bio – markerdetect oral cancer in its earliest stages, the lives of nearly 40,500 people diagnosed annually save. But early detection has been difficult cialis 20mg online . Case Western Reserve University School of Dental Medicine researchers discovered a biomarker, called human beta defensin-3 , an early warning system an early warning system. The defensin is in all oral cancers and with the early stages of oral cancer. Which biomarkers which biomarkers oral cancer holds potential for saving lives when the cancer is highly curable Annually, about 10,000 people die from this cancer ‘ ‘said Ge Jin, assistant professor of biology at the dental school.

Notes1 The Dentists Act makes a criminal offense an offense for anyone other than a registered dentist to perform dentistry The GDC is responsible for protecting the public by invoking the illegal practices committed to justice, it is also. Take offense under the Dentists use a you use a title or description implying that dentist dentist, unless you are a registered dentist. As a UK regulatory authority of the dental profession, the GDC has a duty the to protect public.

- Remember, time pair of quality: a sick child in hospital is a serious constraint on relationships and economically stressed families, especially when there are other siblings involved. Sleep deprivation increases the tension with all the complications that the mother may have in recovery. Create a sleep schedule with your partner and make sure you have quality time with them outside the hospital.

Imagine small children so a wedding ring can fit around their arm. Often weigh less than a pound, very weak and sick children cling to life, connected to a maze of tubes and beeping monitors. Although no parent can ever prepare for high-tech environment of a neonatal intensive care unit (NICU), the reality is more than 500,000 babies are born prematurely each year in the United States. This number continues to rise in part to older women who have children and the increase in multiple births. To prepare parents, care UC San Diego health care system provides a unique program to help alleviate and vulnerable at this time.

‘No parent expects to have their babies in intensive care, but to educate parents and families of this environment and variety of useful resources, we offer throughout pregnancy is the key to be proactive should rise to a premature baby or sick, ‘said Janet Hebert, NICU nurse manager of the UC San Diego Health System.

‘Being in the ICU is like an emotional roller coaster. Breastfeeding is the only thing that can give a mother who normalized their parents when they often feel powerless in the neonatal intensive care…

Goya Foods, Secaucus is having regard to their 14 ounce packages of Frozen Mamey Pulp due to possible public health risks arising salmonella. Any conditions related to in connection with Goya trade mark Mamey Pulp. Recalled Goya brand Mamey Pulp was sold in the states of Cat., and WA through retail stores.
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer
What Is Mouth Cancer

Oral Cancer Symptoms

Source(google.com.pk)
Oral Cancer Symptoms Biography
The extent of treatment for oral cancer depends on a number of factors. Among them are the location, size, type and extent of the tumor and stage of the disease. Your doctor also considers your age and general health. Treatment may involve surgery, radiation therapy or a combination. You also may receive chemotherapy, or treatment with anticancer drugs.

For most patients, it is important to have a complete dental exam before cancer treatment begins. Because cancer treatment may make the mouth sensitive and more easily infected, doctors often advise to have dental work done before treatment begins.

Surgery
Surgery to remove the tumor in the mouth is the usual treatment for patients with oral cancer. If there is evidence that the cancer has spread or a concern that it has spread, the surgeon may also remove lymph nodes in the neck. If the disease has spread to muscles and other tissues in the neck, the operation may be more extensive.

Radiation Therapy
Radiation therapy, also called radiotherapy, is the use of high-energy rays to damage cancer cells and stop them from growing. Like surgery, radiation therapy is local therapy, affecting only the cells in the treated area. The energy may come from a large machine, or external radiation. Patients with large tumors may need both surgery and radiation therapy.

Chemotherapy
Chemotherapy is the use of drugs to kill cancer cells. Researchers are looking for effective drugs or drug combinations to treat oral cancer. They are also exploring ways to combine chemotherapy with other forms of cancer treatment to help destroy the tumor and prevent the disease from spreading.

Reviewed by health care specialists at UCSF Medical Center.
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms
Oral Cancer Symptoms